Good afternoon :)
Place Order
Add to Watchlist

ANG Lifesciences India Ltd

ANG

ANG Lifesciences India Ltd

ANG
Health CarePharmaceuticals
SmallcapWith a market cap of ₹42 cr, stock is ranked 3,589
Moderate RiskStock is 2.93x as volatile as Nifty
31.891.85% (-0.60)
31.891.85% (-0.60)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹42 cr, stock is ranked 3,589
Moderate RiskStock is 2.93x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹42 cr, stock is ranked 3,589
Moderate RiskStock is 2.93x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-3.030.56
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
46.895.970.56%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials

PE Ratio
40.38
1Y Return
1.12%
Buy Reco %
85.29
PE Ratio
28.66
1Y Return
2.75%
Buy Reco %
72.73
PE Ratio
62.75
1Y Return
13.84%
Buy Reco %
68.00
PE Ratio
16.73
1Y Return
12.31%
Buy Reco %
45.16
PE Ratio
48.73
1Y Return
4.48%
Buy Reco %
80.00
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2021FY 2022FY 2023FY 2024TTM
Total Revenue154.93355.20229.61146.81115.41
Raw Materialssubtract140.12234.65156.08102.79113.82
Power & Fuel Costsubtract6.146.504.15
Employee Costsubtract21.2923.9719.35
Selling & Administrative Expensessubtract18.7015.4912.85
Operating & Other expensessubtract5.623.12-1.39
Depreciation/Amortizationsubtract1.335.889.358.377.38
Interest & Other Itemssubtract3.529.4212.4811.4110.10
Taxes & Other Itemssubtract3.1113.192.89-0.57-1.89
EPS4.7431.11-0.21-7.77-10.72
DPS0.800.000.000.00
Payout ratio0.000.030.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2019

Annual report

PDF

Investor Presentation

Jun 14PDF
FY 2022

Annual report

PDF

Investor Presentation

Oct 26PDF
Sep 6PDF
FY 2023

Annual report

PDF

Investor Presentation

Aug 14PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
ANG Lifesciences India Ltd-4.180.56
Sun Pharmaceutical Industries Ltd40.385.760.84%
Cipla Ltd28.664.410.89%
Torrent Pharmaceuticals Ltd62.7515.160.91%

Price Comparison

Compare ANG with any stock or ETF
Compare ANG with any stock or ETF
ANG
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.60%0.00%0.00%0.00%29.40%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Shareholding History

SepDec '23MarJunSepDec '240.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateNov 2, 2021

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 2, 2021

News & Opinions
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 5.19 crore in the December 2024 quarter

Net Loss of ANG Lifesciences India reported to Rs 5.19 crore in the quarter ended December 2024 as against net loss of Rs 5.93 crore during the previous quarter ended December 2023. Sales rose 33.32% to Rs 24.73 crore in the quarter ended December 2024 as against Rs 18.55 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales24.7318.55 33 OPM %-8.69-10.30 - PBDT-4.42-4.45 1 PBT-6.38-6.37 0 NP-5.19-5.93 12 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
ANG Lifesciences India schedules board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.09 crore in the September 2024 quarter

Net Loss of ANG Lifesciences India reported to Rs 2.09 crore in the quarter ended September 2024 as against net loss of Rs 2.32 crore during the previous quarter ended September 2023. Sales declined 1.14% to Rs 32.88 crore in the quarter ended September 2024 as against Rs 33.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.8833.26 -1 OPM %6.964.99 - PBDT0.45-0.41 LP PBT-1.29-2.63 51 NP-2.09-2.32 10 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
ANG Lifesciences India to conduct board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
ANG Lifesciences India to hold AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
ANG Lifesciences India to convene AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 3.07 crore in the June 2024 quarter

Net loss of ANG Lifesciences India reported to Rs 3.07 crore in the quarter ended June 2024 as against net profit of Rs 1.75 crore during the previous quarter ended June 2023. Sales declined 67.39% to Rs 18.41 crore in the quarter ended June 2024 as against Rs 56.46 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.4156.46 -67 OPM %-9.2311.58 - PBDT-2.514.55 PL PBT-4.142.36 PL NP-3.071.75 PL Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
ANG Lifesciences India to discuss results

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

6 months agoCapital Market - Live

North Eastern Carrying Corporation Ltd leads losers in ‘B’ group

1 year agoBusiness Standard

Alps Industries Ltd leads losers in ‘B’ group

2 years agoBusiness Standard

Frequently asked questions

  1. What is the share price of ANG Lifesciences India Ltd (ANG) today?

    The share price of ANG as on 11th March 2025 is ₹31.89. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on ANG Lifesciences India Ltd (ANG) share?

    The past returns of ANG Lifesciences India Ltd (ANG) share are
    • Past 1 week: -5.39%
    • Past 1 month: -17.89%
    • Past 3 months: -31.77%
    • Past 6 months: -43.05%
    • Past 1 year: -45.65%
    • Past 3 years: -82.75%
    • Past 5 years: 146.14%

  3. What are the peers or stocks similar to ANG Lifesciences India Ltd (ANG)?
  4. What is the market cap of ANG Lifesciences India Ltd (ANG) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of ANG Lifesciences India Ltd (ANG) is ₹42.43 Cr as of 11th March 2025.

  5. What is the 52 week high and low of ANG Lifesciences India Ltd (ANG) share?

    The 52-week high of ANG Lifesciences India Ltd (ANG) is ₹63.17 and the 52-week low is ₹29.85.

  6. What is the PE and PB ratio of ANG Lifesciences India Ltd (ANG) stock?

    The P/E (price-to-earnings) ratio of ANG Lifesciences India Ltd (ANG) is -4.18. The P/B (price-to-book) ratio is 0.56.

  7. Which sector does ANG Lifesciences India Ltd (ANG) belong to?

    ANG Lifesciences India Ltd (ANG) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy ANG Lifesciences India Ltd (ANG) shares?

    You can directly buy ANG Lifesciences India Ltd (ANG) shares on Tickertape. Simply sign up, connect your demat account and place your order.